Lupin Limited has informed the Exchange regarding a press release dated July 14, 2023, titled "Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets. USP ".
Lupin Limited has informed the Exchange regarding a press release dated July 14, 2023, titled "Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets. USP ".